ArticleJAMA network open2022

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment.

William S Weintraub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.